Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (36)
Sonia How Ming Wong, Chee-Mun Fang, Hwei-San Loh & Siew Ching Ngai. (2023) Trailing TRAIL Resistance in Human Breast Adenocarcinoma Cells with Trichostatin
A and Zebularine. Anti-Cancer Agents in Medicinal Chemistry 23:7, pages 817-831.
Crossref
Crossref
Fangshan Chen, Xianmei Zhong, Qian Dai, Kuo Li, Wei Zhang, Jie Wang, Yueshui Zhao, Jing Shen, Zhangang Xiao, Hongyun Xing & Jing Li. (2022) Human Umbilical Cord MSC Delivered-Soluble TRAIL Inhibits the Proliferation and Promotes Apoptosis of B-ALL Cell In Vitro and In Vivo. Pharmaceuticals 15:11, pages 1391.
Crossref
Crossref
Artem A. Artykov, Anne V. Yagolovich, Dmitry A. Dolgikh, Mikhail P. Kirpichnikov, Daria B. Trushina & Marine E. Gasparian. (2021) Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Hyeonwoo Je, Gi-Hoon Nam, Gi Beom Kim, Wonjun Kim, Soo Rin Kim, In-San Kim & Eun Jung Lee. (2021) Overcoming therapeutic efficiency limitations against TRAIL-resistant tumors using re-sensitizing agent-loaded trimeric TRAIL-presenting nanocages. Journal of Controlled Release 331, pages 7-18.
Crossref
Crossref
A.L. Heck, S. Mishra, T. Prenzel, L. Feulner, E. Achhammer, V. Särchen, B.S.J. Blagg, W. Schneider-Brachert, S. Schütze & J. Fritsch. (2021) Selective HSP90β inhibition results in TNF and TRAIL mediated HIF1α degradation. Immunobiology 226:2, pages 152070.
Crossref
Crossref
Sonia How Ming Wong, Chee-Mun Fang, Hwei-San Loh & Siew Ching Ngai. (2021) Trichostatin A and Zebularine along with E-cadherin re-expression enhance tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cell cycle arrest in human breast adenocarcinoma cells. Asia Pacific Journal of Molecular Biology and Biotechnology, pages 26-41.
Crossref
Crossref
Siew Ching Ngai. (2020) Curcumin Sensitizes Cancers Towards TRAIL-induced Apoptosis via Extrinsic and Intrinsic Apoptotic Pathways. Current Drug Targets 21:9, pages 849-854.
Crossref
Crossref
Elisabetta Iessi, Matteo Marconi, Valeria Manganelli, Maurizio Sorice, Walter Malorni, Tina Garofalo & Paola Matarrese. 2020. Cell Death Regulation in Health and Disease - Part A. Cell Death Regulation in Health and Disease - Part A
149
195
.
Mengxiong Wang, Mary E. Law, Bradley J. Davis, Elham Yaaghubi, Amanda F. Ghilardi, Renan B. Ferreira, Chi-Wu Chiang, Olga A. Guryanova, Daniel Kopinke, Coy D. Heldermon, Ronald K. Castellano & Brian K. Law. (2019) Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway. Cell Death Discovery 5:1.
Crossref
Crossref
Wei Yang Kong, Zong Yang Yee, Chun Wai Mai, Chee-Mun Fang, Syahril Abdullah & Siew Ching Ngai. (2019) Zebularine and trichostatin A sensitized human breast adenocarcinoma cells towards tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis. Heliyon 5:9, pages e02468.
Crossref
Crossref
Ufuk Mert, Alshaimaa Adawy, Elisabeth Scharff, Pierre Teichmann, Anna Willms, Verena Haselmann, Cynthia Colmorgen, Johannes Lemke, Silvia von Karstedt, Jürgen Fritsch & Anna Trauzold. (2019) TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors. Cancers 11:8, pages 1167.
Crossref
Crossref
Thorsten Heilmann, Florian Vondung, Christoph Borzikowsky, Silke Szymczak, Sandra Krüger, Ibrahim Alkatout, Antonia Wenners, Maret Bauer, Wolfram Klapper, Christoph Röcken, Nicolai Maass, Silvia von Karstedt, Christian Schem & Anna Trauzold. (2019) Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients. Journal of Molecular Medicine 97:8, pages 1155-1167.
Crossref
Crossref
Qinghua Li, Youcheng Ding, Xinlai Guo, Shenggen Luo, Huiren Zhuang, JingE Zhou, Nan Xu & Zhiqiang Yan. (2019) Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo. Journal of Cellular and Molecular Medicine 23:3, pages 1951-1962.
Crossref
Crossref
Julianne D. Twomey, Liqun Zhao, Shen Luo, Qing Xu & Baolin Zhang. (2018) Tubulin couples death receptor 5 to regulate apoptosis. Oncotarget 9:95, pages 36804-36815.
Crossref
Crossref
Michael B. Deci, Maixian Liu, Quoc Thai Dinh & Juliane Nguyen. (2018) Precision engineering of targeted nanocarriers. WIREs Nanomedicine and Nanobiotechnology 10:5.
Crossref
Crossref
You-Take Oh, Guoqing Qian, Jiusheng Deng & Shi-Yong Sun. (2018) Monocyte chemotactic protein-induced protein-1 enhances DR5 degradation and negatively regulates DR5 activation-induced apoptosis through its deubiquitinase function. Oncogene 37:25, pages 3415-3425.
Crossref
Crossref
Attila Keresztes & John M. Streicher. (2017) Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer therapies?. FEBS Letters 591:20, pages 3235-3251.
Crossref
Crossref
Ufuk Mert & Ahter Dilsad Sanlioglu. (2016) Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer. Cellular and Molecular Life Sciences 74:2, pages 245-255.
Crossref
Crossref
Juanjuan Zhu, Qiujing Zhou & Shuhua Tan. (2016) Targeting miRNAs associated with surface expression of death receptors to modulate TRAIL resistance in breast cancer. Cancer Letters 383:2, pages 154-160.
Crossref
Crossref
Jürgen Fritsch, Ricarda Fickers, Jan Klawitter, Vinzenz Särchen, Philipp Zingler, Dieter Adam, Ottmar Janssen, Eberhard Krause & Stefan Schütze. (2016) TNF induced cleavage of HSP90 by cathepsin D potentiates apoptotic cell death. Oncotarget 7:46, pages 75774-75789.
Crossref
Crossref
Ana Cano-González & Abelardo López-Rivas. (2016) Opposing roles of TGF-β and EGF in the regulation of TRAIL-induced apoptosis in human breast epithelial cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863:8, pages 2104-2114.
Crossref
Crossref
Julianne D. Twomey, Su-Ryun Kim, Liqun Zhao, William P. Bozza & Baolin Zhang. (2015) Spatial dynamics of TRAIL death receptors in cancer cells. Drug Resistance Updates 19, pages 13-21.
Crossref
Crossref
Julianne D. Twomey, William Hallett & Baolin Zhang. 2015. Resistance of Cancer Cells to CTL-Mediated Immunotherapy. Resistance of Cancer Cells to CTL-Mediated Immunotherapy
209
233
.
Eun Ah Shin, Eun Jung Sohn, Gunho Won, Jeong-Un Choi, Myongsuk Jeong, Bonglee Kim, Min-Jeong Kim & Sung-Hoon Kim. (2014) Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis. Oncotarget 5:14, pages 5624-5636.
Crossref
Crossref
Jun-Jie Chen, William P. Bozza, Xu Di, Yaqin Zhang, William Hallett & Baolin Zhang. (2014) H-Ras regulation of TRAIL death receptor mediated apoptosis. Oncotarget 5:13, pages 5125-5137.
Crossref
Crossref
Deborah A. Flusberg, Jérémie Roux, Sabrina L. Spencer & Peter K. Sorger. (2013) Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes. Molecular Biology of the Cell 24:14, pages 2186-2200.
Crossref
Crossref
Samy A. F. Morad & Myles C. Cabot. (2012) Ceramide-orchestrated signalling in cancer cells. Nature Reviews Cancer 13:1, pages 51-65.
Crossref
Crossref
Conghua Xie. (2012) Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells. International Journal of Oncology.
Crossref
Crossref
N Mazurek, J C Byrd, Y Sun, M Hafley, K Ramirez, J Burks & R S Bresalier. (2011) Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells. Cell Death & Differentiation 19:3, pages 523-533.
Crossref
Crossref
Ammad Farooqi, Shahzad Bhatti & Muhammad Ismail. (2012) TRAIL and vitamins: opting for keys to castle of cancer proteome instead of open sesame. Cancer Cell International 12:1, pages 22.
Crossref
Crossref
Jun-Jie Chen, Steen Knudsen, Wiktor Mazin, Jesper Dahlgaard & Baolin Zhang. (2012) A 71-Gene Signature of TRAIL Sensitivity in Cancer Cells. Molecular Cancer Therapeutics 11:1, pages 34-44.
Crossref
Crossref
Karen Bräutigam, Julia Biernath-Wüpping, Dirk O. Bauerschlag, Constantin S. von Kaisenberg, Walter Jonat, Nicolai Maass, Norbert Arnold & Ivo Meinhold-Heerlein. (2010) Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines. Journal of Cancer Research and Clinical Oncology 137:5, pages 875-886.
Crossref
Crossref
Joslyn K. Brunelle & Baolin Zhang. (2010) Apoptosis assays for quantifying the bioactivity of anticancer drug products. Drug Resistance Updates 13:6, pages 172-179.
Crossref
Crossref
Darren Finlay, Robyn D. Richardson, Lisa K. Landberg, Amy L. Howes & Kristiina Vuori. (2010) Novel HTS Strategy Identifies TRAIL-Sensitizing Compounds Acting Specifically Through the Caspase-8 Apoptotic Axis. PLoS ONE 5:10, pages e13375.
Crossref
Crossref
Tatsushi Yoshida, Yaqin Zhang, Leslie A. Rivera Rosado & Baolin Zhang. (2009) Repeated Treatment with Subtoxic Doses of TRAIL Induces Resistance to Apoptosis through Its Death Receptors in MDA-MB-231 Breast Cancer Cells. Molecular Cancer Research 7:11, pages 1835-1844.
Crossref
Crossref
Monzur Rahman, Janet G. Pumphrey & Stanley Lipkowitz. 2009.
43
73
.